# Sera Prognostics, Inc.: filings

SERA · Nasdaq · CIK 1534969 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sera.md) · [Financials](/companies/sera/financials.md) · [Filings](/companies/sera/filings.md) · [Insiders](/companies/sera/insiders.md)

## Reports and events: 86 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 283, 144 177, 8-K 52, 3 28, 10-Q 16, D 9, SC 13G/A 9, SC 13G 7, DEFA14A 6, S-8 6, 10-K 5, CORRESP 5, DEF 14A 5, SCHEDULE 13G/A 5, 424B5 4, ARS 4, D/A 4, SEC STAFF LETTER 4, UPLOAD 4, 8-K/A 3, DRS/A 2, DRSLTR 2, EFFECT 2, SCHEDULE 13G 2, 3/A 1, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DRS 1, PRE 14A 1, S-1 1, S-1/A 1, S-3 1, SC 13D 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-19 | 21:05 ET | [8-K](/filings/0001193125-26-357112.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-357112 |
| 2026-08-12 | 20:11 ET | [10-Q](/filings/0001193125-26-346862.md) | Quarterly report, period 2026-06-30 | 0001193125-26-346862 |
| 2026-08-12 | 20:08 ET | [8-K](/filings/0001193125-26-346846.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-346846 |
| 2026-06-30 | 20:09 ET | [8-K](/filings/0001534969-26-000035.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001534969-26-000035 |
| 2026-06-04 | 21:13 ET | [8-K](/filings/0001534969-26-000032.md) | 5.07 Shareholder vote results | 0001534969-26-000032 |
| 2026-06-01 | 20:44 ET | [8-K](/filings/0001534969-26-000028.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001534969-26-000028 |
| 2026-05-06 | 20:08 ET | [10-Q](/filings/0001534969-26-000025.md) | Quarterly report, period 2026-03-31 | 0001534969-26-000025 |
| 2026-05-06 | 20:06 ET | [8-K](/filings/0001534969-26-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-26-000024 |
| 2026-04-24 | 20:10 ET | [DEF 14A](/filings/0001534969-26-000018.md) | Proxy statement, period 2026-04-23 | 0001534969-26-000018 |
| 2026-03-18 | 20:08 ET | [10-K](/filings/0001534969-26-000009.md) | Annual report, period 2025-12-31 | 0001534969-26-000009 |
| 2026-03-18 | 20:06 ET | [8-K](/filings/0001534969-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-26-000008 |
| 2026-01-08 | 22:20 ET | [8-K](/filings/0001193125-26-007850.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-007850 |
| 2026-01-07 | 14:12 ET | [8-K](/filings/0001193125-26-005531.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-005531 |
| 2025-11-24 | 13:05 ET | [8-K](/filings/0001193125-25-292074.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-292074 |
| 2025-11-13 | 21:12 ET | [10-Q](/filings/0001193125-25-280182.md) | Quarterly report, period 2025-09-30 | 0001193125-25-280182 |
| 2025-11-13 | 21:09 ET | [8-K](/filings/0001193125-25-280167.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-280167 |
| 2025-09-05 | 20:05 ET | [8-K](/filings/0001534969-25-000005.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001534969-25-000005 |
| 2025-08-06 | 20:09 ET | [10-Q](/filings/0000950170-25-104007.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104007 |
| 2025-08-06 | 20:07 ET | [8-K](/filings/0000950170-25-103994.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103994 |
| 2025-06-05 | 21:28 ET | [8-K](/filings/0000950170-25-082539.md) | 5.07 Shareholder vote results | 0000950170-25-082539 |
| 2025-05-08 | 21:20 ET | [8-K](/filings/0000950170-25-067231.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-067231 |
| 2025-05-07 | 20:12 ET | [10-Q](/filings/0000950170-25-065667.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065667 |
| 2025-05-07 | 20:09 ET | [8-K](/filings/0000950170-25-065654.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065654 |
| 2025-04-23 | 20:10 ET | [DEF 14A](/filings/0000950170-25-057359.md) | Proxy statement, period 2025-06-05 | 0000950170-25-057359 |
| 2025-03-19 | 20:16 ET | [10-K](/filings/0000950170-25-042017.md) | Annual report, period 2024-12-31 | 0000950170-25-042017 |
| 2025-03-19 | 20:13 ET | [8-K](/filings/0000950170-25-042005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-042005 |
| 2025-02-14 | 22:00 ET | [SCHEDULE 13D/A](/filings/0001213900-25-014395.md) | Ownership report, active investor, amended | 0001213900-25-014395 |
| 2025-02-14 | 21:33 ET | [SCHEDULE 13D](/filings/0001104659-25-014220.md) | Ownership report, active investor | 0001104659-25-014220 |
| 2025-02-12 | 01:46 ET | [8-K](/filings/0001193125-25-024518.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-024518 |
| 2025-02-10 | 21:08 ET | [8-K](/filings/0001193125-25-023577.md) | 8.01 Other events | 0001193125-25-023577 |
| 2025-01-31 | 18:31 ET | [8-K](/filings/0001193125-25-018170.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-018170 |
| 2025-01-13 | 22:26 ET | [8-K](/filings/0000950170-25-004909.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004909 |
| 2025-01-07 | 22:21 ET | [8-K](/filings/0000950170-25-003021.md) | 7.01 Regulation FD disclosure | 0000950170-25-003021 |
| 2024-11-06 | 21:11 ET | [10-Q](/filings/0000950170-24-122312.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122312 |
| 2024-11-06 | 21:10 ET | [8-K](/filings/0000950170-24-122288.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122288 |
| 2024-08-07 | 20:14 ET | [10-Q](/filings/0001534969-24-000152.md) | Quarterly report, period 2024-06-30 | 0001534969-24-000152 |
| 2024-08-07 | 20:11 ET | [8-K](/filings/0001534969-24-000151.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-24-000151 |
| 2024-06-06 | 20:06 ET | [8-K](/filings/0001534969-24-000122.md) | 5.07 Shareholder vote results | 0001534969-24-000122 |
| 2024-05-08 | 20:13 ET | [10-Q](/filings/0001534969-24-000085.md) | Quarterly report, period 2024-03-31 | 0001534969-24-000085 |
| 2024-05-08 | 20:09 ET | [8-K](/filings/0001534969-24-000084.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-24-000084 |
| 2024-04-23 | 20:06 ET | [DEF 14A](/filings/0001534969-24-000077.md) | Proxy statement, period 2024-06-06 | 0001534969-24-000077 |
| 2024-03-20 | 20:10 ET | [10-K](/filings/0001534969-24-000055.md) | Annual report, period 2023-12-31 | 0001534969-24-000055 |
| 2024-03-20 | 20:08 ET | [8-K](/filings/0001534969-24-000054.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001534969-24-000054 |
| 2023-12-12 | 21:05 ET | [8-K](/filings/0001534969-23-000127.md) | 1.01 Entry into a material agreement | 0001534969-23-000127 |
| 2023-12-06 | 13:49 ET | [8-K](/filings/0001534969-23-000121.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001534969-23-000121 |
| 2023-11-08 | 21:10 ET | [10-Q](/filings/0001534969-23-000112.md) | Quarterly report, period 2023-09-30 | 0001534969-23-000112 |
| 2023-11-08 | 21:08 ET | [8-K](/filings/0001534969-23-000111.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-23-000111 |
| 2023-09-25 | 12:52 ET | [8-K](/filings/0001534969-23-000096.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001534969-23-000096 |
| 2023-08-09 | 20:13 ET | [10-Q](/filings/0001534969-23-000092.md) | Quarterly report, period 2023-06-30 | 0001534969-23-000092 |
| 2023-08-09 | 20:11 ET | [8-K](/filings/0001534969-23-000091.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-23-000091 |

Page 1 of 2. [Older](/companies/sera/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.